HPS Pharmacies wish to advise that Bayer Australia is experiencing a supply interruption for Mirena® as follows:
Normal supplies of Mirena® are expected to resume by early September 2023.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact Bayer Australia on 1800 008 757, or your pharmacist at HPS Pharmacies.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates